These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34811646)

  • 1. Excess branched-chain amino acids alter myotube metabolism and substrate preference which is worsened by concurrent insulin resistance.
    Rivera ME; Rivera CN; Vaughan RA
    Endocrine; 2022 Apr; 76(1):18-28. PubMed ID: 34811646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose Reduces Mitochondrial Metabolism and Increases Extracellular BCAA during Insulin Resistance in C2C12 Myotubes.
    Cook NE; McGovern MR; Zaman T; Lundin PM; Vaughan RA
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of valine on myotube insulin sensitivity and metabolism with and without insulin resistance.
    Rivera ME; Lyon ES; Johnson MA; Sunderland KL; Vaughan RA
    Mol Cell Biochem; 2020 May; 468(1-2):169-183. PubMed ID: 32222880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain amino acids at supraphysiological but not physiological levels reduce myotube insulin sensitivity.
    Rivera ME; Rivera CN; Vaughan RA
    Diabetes Metab Res Rev; 2022 Feb; 38(2):e3490. PubMed ID: 34397159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BCKDH kinase inhibitor BT2 promotes BCAA disposal and mitochondrial proton leak in both insulin-sensitive and insulin-resistant C2C12 myotubes.
    Rivera CN; Smith CE; Draper LV; Kee ME; Cook NE; McGovern MR; Watne RM; Wommack AJ; Vaughan RA
    J Cell Biochem; 2024 Mar; 125(3):e30520. PubMed ID: 38226684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine increases mitochondrial metabolism and lipid content without altering insulin signaling in myotubes.
    Rivera ME; Lyon ES; Johnson MA; Vaughan RA
    Biochimie; 2020 Jan; 168():124-133. PubMed ID: 31682874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine, Palmitate, or Leucine/Palmitate Cotreatment Enhances Myotube Lipid Content and Oxidative Preference.
    Johnson MA; Gannon NP; Schnuck JK; Lyon ES; Sunderland KL; Vaughan RA
    Lipids; 2018 Nov; 53(11-12):1043-1057. PubMed ID: 30706482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AICAR stimulates mitochondrial biogenesis and BCAA catabolic enzyme expression in C2C12 myotubes.
    Hinkle JS; Rivera CN; Vaughan RA
    Biochimie; 2022 Apr; 195():77-85. PubMed ID: 34798200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of chronic physiological 3-hydroxyisobuterate treatment on mitochondrial metabolism and insulin signaling in myotubes.
    Lyon ES; Rivera ME; Johnson MA; Sunderland KL; Vaughan RA
    Nutr Res; 2019 Jun; 66():22-31. PubMed ID: 31051319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess Branched-Chain Amino Acids Suppress Mitochondrial Function and Biogenic Signaling but Not Mitochondrial Dynamics in a Myotube Model of Skeletal Muscle Insulin Resistance.
    VanDerStad LR; Wyatt EC; Vaughan RA
    Metabolites; 2024 Jul; 14(7):. PubMed ID: 39057712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Selective LAT1 Inhibitor JPH203 Enhances Mitochondrial Metabolism and Content in Insulin-Sensitive and Insulin-Resistant C2C12 Myotubes.
    Rivera CN; Smith CE; Draper LV; Ochoa GE; Watne RM; Wommack AJ; Vaughan RA
    Metabolites; 2023 Jun; 13(6):. PubMed ID: 37367923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mTORC Agonism via MHY1485 with and without Rapamycin on C2C12 Myotube Metabolism.
    Cook NE; McGovern MR; Zaman T; Lundin PM; Vaughan RA
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological 4-phenylbutyrate promotes mitochondrial biogenesis and metabolism in C2C12 myotubes.
    Rivera CN; Smith CE; Draper LV; Watne RM; Wommack AJ; Vaughan RA
    Biochimie; 2024 Apr; 219():155-164. PubMed ID: 38008282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aza-2'-deoxycytidine-mediated DNA hypomethylation with and without concurrent insulin resistance suppresses myotube mitochondrial capacity.
    Rivera CN; Kamer MM; Cook NE; McGovern MR; Watne RM; Wommack AJ; Vaughan RA
    Cell Biochem Funct; 2023 Dec; 41(8):1422-1429. PubMed ID: 37916846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of insulin resistance on extracellular BCAA accumulation and SLC25A44 expression in a myotube model of skeletal muscle insulin resistance.
    Rivera CN; Watne RM; Wommack AJ; Vaughan RA
    Amino Acids; 2023 Nov; 55(11):1701-1705. PubMed ID: 37740788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance promotes extracellular BCAA accumulation without altering LAT1 content, independent of prior BCAA treatment in a myotube model of skeletal muscle.
    Rivera CN; Kamer MM; Rivera ME; Watne RM; Macgowan TC; Wommack AJ; Vaughan RA
    Mol Cell Endocrinol; 2023 Jan; 559():111800. PubMed ID: 36270542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metformin on myotube BCAA catabolism.
    Rivera ME; Lyon ES; Vaughan RA
    J Cell Biochem; 2020 Jan; 121(1):816-827. PubMed ID: 31385363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the effects of palmitate, insulin, and palmitate-insulin co-treatment on myotube metabolism and insulin resistance.
    Rivera ME; Vaughan RA
    Lipids; 2021 Nov; 56(6):563-578. PubMed ID: 34382222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess glutamine does not alter myotube metabolism or insulin sensitivity.
    Krone MJ; Rivera CN; Rivera ME; Watne RM; Lemonds SE; Wommack AJ; Vaughan RA
    Amino Acids; 2022 Mar; 54(3):455-468. PubMed ID: 35112170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.